Investor Alert

press release

Nov. 18, 2021, 4:10 p.m. EST

Dynavax to Present at the 4th Annual Evercore Virtual ISI HealthCONx Conference

EMERYVILLE, Calif., Nov. 18, 2021 /PRNewswire/ --  Dynavax Technologies Corporation /zigman2/quotes/203017054/composite DVAX +6.42% , a biopharmaceutical company focused on developing and commercializing novel vaccines, today announced that Ryan Spencer , Chief Executive Officer, will participate in a virtual fireside chat at the 4th Annual Evercore virtual ISI HealthCONx Conference on Tuesday, November 30, at 2:40 p. m. E.T.

The live audio webcast may be accessed through the "Events & Presentations" page on the "Investors" section of the Company's website at http://investors.dynavax.com/events-presentations . A replay of the webcast will be available for 30 days following the live event.

About Dynavax Dynavax is a commercial stage biopharmaceutical company developing and commercializing novel vaccines. The Company's first commercial product, HEPLISAV-B® [Hepatitis B Vaccine (Recombinant), Adjuvanted], is approved in the U.S. and the European Union for prevention of infection caused by all known subtypes of hepatitis B virus in adults age 18 years and older. Dynavax is also advancing CpG 1018 adjuvant as a premier vaccine adjuvant through research collaborations and partnerships. Current collaborations are focused on adjuvanted vaccines for COVID-19, plague, Tdap, and universal influenza. For more information, visit www.dynavax.com and follow the company on LinkedIn .

Contacts: Nicole Arndt, Investor Relations and Corporate Communications

Derek Cole, President
Investor Relations Advisory Solutions

View original content to download multimedia: https://www.prnewswire.com/news-releases/dynavax-to-present-at-the-4th-annual-evercore-virtual-isi-healthconx-conference-301428589.html

SOURCE Dynavax Technologies


Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

Copyright (C) 2021 PR Newswire. All rights reserved

US : U.S.: Nasdaq
$ 12.43
+0.75 +6.42%
Volume: 3.02M
May 27, 2022 4:00p
P/E Ratio
Dividend Yield
Market Cap
$1.48 billion
Rev. per Employee


Partner Center

Link to MarketWatch's Slice.